B
Beatriz de Camargo
Researcher at Gdańsk Medical University
Publications - 143
Citations - 4156
Beatriz de Camargo is an academic researcher from Gdańsk Medical University. The author has contributed to research in topics: Wilms' tumor & Cancer. The author has an hindex of 33, co-authored 137 publications receiving 3575 citations. Previous affiliations of Beatriz de Camargo include University of São Paulo.
Papers
More filters
Journal ArticleDOI
Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
Jozsef Zsiros,Rudolf Maibach,E. Shafford,Laurence Brugières,Penelope Brock,Piotr Czauderna,Derek J. Roebuck,Margaret Childs,Arthur Zimmermann,Véronique Laithier,Jean-Bernard Otte,Beatriz de Camargo,Gordon A. MacKinlay,Marcelo Scopinaro,Daniel C. Aronson,Jack Plaschkes,Giorgio Perilongo +16 more
TL;DR: The applied treatment rendered a great proportion of tumors resectable, and, in comparison with previously published results, led to an improved survival in patients with high-risk hepatoblastoma.
Journal ArticleDOI
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
Giorgio Perilongo,Rudolf Maibach,Elisabeth Shafford,Laurence Brugières,Penelope Brock,Bruce Morland,Beatriz de Camargo,Jozsef Zsiros,Derek J. Roebuck,Arthur Zimmermann,Daniel C. Aronson,Margaret Childs,Eva Widing,Véronique Laithier,Jack Plaschkes,Jon Pritchard,Marcello Scopinaro,Gordon A. MacKinlay,Piotr Czauderna +18 more
TL;DR: Cisplatin monotherapy achieved similar rates of complete resection and survival among children with standard-risk hepatoblastoma and doxorubicin can be safely omitted from the treatment of standard- risk hepatoblowlastoma.
Journal ArticleDOI
Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
Marry M. van den Heuvel-Eibrink,Janna A. Hol,Kathy Pritchard-Jones,Harm van Tinteren,Rhoikos Furtwängler,Arnauld Verschuur,Gordan M. Vujanic,Ivo Leuschner,Jesper Brok,Christian Rübe,Anne M. J. B. Smets,Geert O. Janssens,J. Godzinski,Gema L. Ramírez-Villar,Beatriz de Camargo,Heidi Segers,Paola Collini,Manfred Gessler,Christophe Bergeron,Filippo Spreafico,Norbert Graf +20 more
TL;DR: The UMBRELLA protocol will support integrated biomarker and imaging research, focussing on assessing the independent prognostic value of genomic changes within the tumour and the volume of the blastemal component that survives preoperative chemotherapy.
Journal ArticleDOI
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
A. Sergio Petrilli,Beatriz de Camargo,Vicente Odone Filho,Paula Bruniera,A. L. Brunetto,Reynaldo Jesus-Garcia,Olavo Pires de Camargo,Walter Pena,Pedro Pericles,Alexandre Davi,José Donato de Próspero,Maria Teresa de Seixas Alves,Claudia Regina G. C. M. Oliveira,Carla Renata Pacheco Donato Macedo,Wellington Luiz Mendes,M. T. A Almeida,Maria Luisa Borsato,Telma Murias dos Santos,Jorge A. Ortega,Elio Consentino +19 more
TL;DR: The overall 5- and 10-year survival rates were lower than the rates reported in North American and European trials and a pattern of advanced disease at diagnosis was often present, with a high proportion of patients having metastases and large tumor size.
Journal ArticleDOI
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Giovana Tardin Torrezan,Elisa Napolitano Ferreira,Adriana M. Nakahata,Bruna D. F. Barros,Mayara T. M. Castro,Bruna R. Correa,Ana Cristina Victorino Krepischi,Eloisa Helena Ribeiro Olivieri,Isabela Werneck da Cunha,Uri Tabori,Paul E. Grundy,Cecília Maria Lima da Costa,Beatriz de Camargo,Pedro A. F. Galante,Dirce Maria Carraro +14 more
TL;DR: The data underscore the pivotal role of the miRNA biogenesis pathway in WT tumorigenesis, particularly the major miRNA-processing gene DROSHA, which leads to a predominant downregulation of a subset of miRNAs.